Medigensp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-01-20
Share capital
50 000,00 PLN
Activity description

Medigen is a medical entity that specializes in selecting the best bone marrow donors and conducting complex diagnostic tests for patients with leukemia and other hematological diseases. It provides comprehensive support for patients and their families, addressing various issues they encounter. Medigen is also the only laboratory in the country with all necessary certifications to ensure the highest quality of its services in the European Union and beyond.

Registered address
ul. Kościelna 61, 05-135 Wieliszew, Poland
Website
medigen.plWebsite active
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 501.90kMedianUSD 92.20kAverageUSD 1.47m
Net profit
This companyUSD -31.75kMedianUSD 2.47kAverageUSD 170.66k
Operating costs
This companyUSD 492.60kMedianUSD 85.28kAverageUSD 1.19m
Assets
This companyUSD 198.60kMedianUSD 40.78kAverageUSD 1.02m

Bank accounts

Registered as a VAT taxpayer on 2003-10-22. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $40,579.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$692
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,484
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,806

European Funds

ProjectEU co-financing
Zakup usług B+R do metod analizy statystycznej wyników dopasowania genotypów HLA (II poziomu) zbadanej populacji próbek europejskich dawców i biorców, jak i wsparcia wytworzenia mechanizmu prototypu modułu informatycznego walidacji statystycznej, dotyczącej zagadnienia analizy i doboru dawców na podstawie niezgodności genetycznej od poziomu 7/10 w procesie badań i wyników testów genetyki laboratoryjnej.
$26,100

Tenders

1 tender recorded as contractor.

SubjectAmount
Konkurs ofert na udzielenie świadczeń zdrowotnych
—

Authorized Representatives

Dagmara Maria Sankowska — Attorney-in-fact (sole)
Monika Jadwiga Sankowska — President of the Management Board

Manner of representation

In the case of a multi-member management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to submit declarations of will on behalf of the company. In the case of a one-person management board, a member of the management board acting independently is authorized to submit declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Monika Jadwiga Sankowska (64)
100$13,506.21100%

Beneficial owners

Person
Monika Jadwiga Sankowska (64)

Subsidiaries

NameStake
Medismartsp. z o.o.
99%

Competitors

Name
Vitaimmun Drobczyńska, Szachtasp. k.
Medic Housesp. z o.o.
Laboratorium Analiz Lekarskich Laborsp. z o.o.
Vivamedsp. z o.o.
CD Słodczyksp. z o.o.
Prime Medicalsp. z o.o.
Astimedsp. z o.o.
Pragamedsp. z o.o.
Navigare Medycyna Rodzinnasp. z o.o.
Klinika Sanosp. z o.o.

Change history

DateEvent
2024-09-06Address change
2024-05-23Address change
2020-11-26PKD change
2013-11-25PKD change
2012-03-26PKD change

FAQ

Last updated: 2026-07-23